Literature DB >> 21874217

Are all melanomas dangerous?

Carsten Nørgaard1, Martin Glud, Robert Gniadecki.   

Abstract

The increased incidence of cutaneous malignant melanoma, together with only minor changes in mortality, has brought into question the existence of a melanoma epidemic. The discrepancy between incidence and mortality suggests that most newly diagnosed melanomas have indolent behaviour. This review summarizes the most recent epidemiological findings regarding the incidence of cutaneous malignant melanoma, mortality, Breslow thickness and clinical stage. Studies published between 2005 and 2010 with more than 2,000 test subjects were included in this review. These studies all report an increase in incidence of melanoma during the last few decades, with by far the highest increase in tumours at a very early stage (T1 or IA). Little or no change was seen in mortality. However, increases in both mortality and incidence of thick melanomas were found in the oldest subgroups, especially in men. These findings indicate the existence of a certain degree of overdiagnosis of melanoma. They also indicate the existence of two different types of epidemic, for younger and older subgroups.

Entities:  

Mesh:

Year:  2011        PMID: 21874217     DOI: 10.2340/00015555-1177

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  4 in total

1.  Screening for reducing morbidity and mortality in malignant melanoma.

Authors:  Minna Johansson; John Brodersen; Peter C Gøtzsche; Karsten Juhl Jørgensen
Journal:  Cochrane Database Syst Rev       Date:  2019-06-03

2.  A Cohort Study: Comorbidity and Stage Affected the Prognosis of Melanoma Patients in Taiwan.

Authors:  Chin-Kuo Chang; Yih-Shou Hsieh; Pei-Ni Chen; Shu-Chen Chu; Jing-Yang Huang; Yu-Hsun Wang; James Cheng-Chung Wei
Journal:  Front Oncol       Date:  2022-03-03       Impact factor: 6.244

3.  Cutaneous Melanoma Systematic Diagnostic Workflows and Integrated Reflectance Confocal Microscopy Assessed with a Retrospective, Comparative Longitudinal (2009-2018) Study.

Authors:  Giovanni Pellacani; Francesca Farnetani; Johanna Chester; Shaniko Kaleci; Silvana Ciardo; Sara Bassoli; Alice Casari; Caterina Longo; Marco Manfredini; Anna Maria Cesinaro; Francesca Giusti; Antonio Iacuzio; Mario Migaldi
Journal:  Cancers (Basel)       Date:  2022-02-07       Impact factor: 6.639

4.  The impact of comorbidity and stage on prognosis of Danish melanoma patients, 1987-2009: a registry-based cohort study.

Authors:  A F Grann; T Frøslev; A B Olesen; H Schmidt; T L Lash
Journal:  Br J Cancer       Date:  2013-05-16       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.